GlassScriptPhysician profile
Raymond K Herr
NPI 1750425542
$1,736.36
in general payments reported to CMS, 2019-2025
18 companies · $438 in 2025
The $438 reported for 2025 was more than what 82% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $130 · 2023: $245 · 2024: $923 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $228.50 | 2023-2025 | Immunocap |
| Novo Nordisk INC | $197.41 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Viiv Healthcare Company | $184.60 | 2024-2025 | Apretude |
| Abbott Laboratories | $149.82 | 2023 | Aveir |
| Sanofi-Aventis U.S. LLC | $142.73 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $122.24 | 2024-2025 | Rexulti |
| Genzyme Corporation | $121.84 | 2024 | |
| Gilead Sciences, INC. | $120.72 | 2024-2025 | |
| Exact Sciences Corporation | $86.95 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $79.13 | 2022-2025 | |
| Abbvie INC. | $55.88 | 2022-2023 | |
| Hologic Sales and Service, LLC | $51.32 | 2024 | Aptima |
| Lilly USA, LLC | $48.69 | 2022-2023 | Mounjaro |
| Philips North America LLC | $38.68 | 2024 | (Ck7) Extended Holter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.79 | 2024-2025 | Xifaxan, Trulance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $34.90 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.32 | 2024 | Breztri |
| Novartis Pharmaceuticals Corporation | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Herr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.